Patients diagnosed with lymphoma and solid organ cancer with venous thromboembolism Cancer
Conditions
Interventions
CAT patients treated with LMWHs,CAT patients treated with warfarin,CAT patients treated with DOACs,CAT patients without anticoagulants
Group 1 LMWHs,Group 2 Warfarin,Group 3 DOACs,Group 4 None
Sponsors
Department of Medicine, Siriraj Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients aged of 18 years or older. 2. Confirmed histological diagnosis of solid organ cancer or lymphoma, meeting at least one of the following conditions: -Newly diagnosed: Confirmed by biopsy within the past 6 months. -Disease Status: Recurrent, refractory, or metastatic cancer. -Active Treatment: Currently undergoing treatment, including surgery, chemotherapy, targeted therapy, or radiation therapy. 3. A recent diagnosis of CA-VTE within the past 3 months, involving at least one of the following: -Symptomatic or Incidental DVT/PE: Deep Vein Thrombosis of the leg or Pulmonary Embolism, confirmed by Doppler ultrasonography, CT Pulmonary Angiography (CTPA), or V/Q scan. -Upper Extremity DVT: Deep Vein Thrombosis of the arm. -Unusual Site Thrombosis: Including cerebral venous sinus thrombosis, mesenteric vein thrombosis, or inferior vena cava (IVC) thrombosis. 4. The CA-VTE must have been diagnosed within one of the following windows: -Between 1 week and 6 months following the initial cancer diagnosis. -During active cancer treatment. -During a period of cancer recurrence.
Exclusion criteria
Exclusion criteria: 1.missing data 2.pregnancy 3.anticoagulant used in other indications 4.unconfirmed VTE 5.Superficial Vein Thrombosis 6.Benign tumor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrent thrombosis 12 months Doppler Ultrasound, CTA pulmonary artery, CTV, CT with contrast | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleeding events 12 months Clinical Diagnosis, CT scan, CBC (for evaluate Hb Hct level) | — |
Countries
Thailand
Contacts
Public ContactTarinee Rungjirajitranon
Division of Hematology, Department of Medicine Siriraj Hospital
Outcome results
None listed